Woody, C.A.; Ferrari, A.J.; Siskind, D.J.; Whiteford, H.A.; Harris, M.G. A systematic review and meta-regression of the prevalence and incidence of perinatal depression. J. Affect. Disord. 2017, 219, 86-92.
Posmontier, B. Functional status outcomes in mothers with and without postpartum depression. J. Midwifery Women’s Health 2008, 53, 310-318.
Letourneau, N.L.; Dennis, C.-L.; Benzies, K.; Duffett-Leger, L.; Stewart, M.; Tryphonopoulos, P.D.; Este, D.; Watson, W. Postpartum Depression is a Family Affair: Addressing the Impact on Mothers, Fathers, and Children. Issues Ment. Health Nurs. 2012, 33, 445-457.
Field, T. Postpartum depression effects on early interactions, parenting, and safety practices: A review. Infant Behav. Dev. 2010, 33, 1-6.
Righetti-Veltema, M.; Conne-Perréard, E.; Bousquet, A.; Manzano, J. Postpartum depression and mother-infant relationship at 3 months old. J. Affect. Disord. 2002, 70, 291-306.
Closa-Monasterolo, R.; Gispert-Llaurado, M.; Canals, J.; Luque, V.; Zaragoza-Jordana, M.; Koletzko, B.; Grote, V.; Weber, M.; Gruszfeld, D.; Szott, K. et al. The Effect of Postpartum Depression and Current Mental Health Problems of the Mother on Child Behaviour at Eight Years. Matern. Child Health J. 2017, 21, 1563-1572.
Kingston, D.; Tough, S. Prenatal and Postnatal Maternal Mental Health and School-Age Child Development: A Systematic Review. Matern. Child Health J. 2014, 18, 1728-1741.
Khan, A.; Faucett, J.; Lichtenberg, P.; Kirsch, I.; Brown, W.A. A Systematic Review of Comparative Efficacy of Treatments and Controls for Depression. PLoS ONE 2012, 7, e41778.
Fournier, J.C.; DeRubeis, R.J.; Hollon, S.D.; Dimidjian, S.; Amsterdam, J.D.; Shelton, R.C.; Fawcett, J. Antidepressant Drug Effects and Depression Severity. JAMA 2010, 303, 47.
Molenaar, N.M.; Kamperman, A.M.; Boyce, P.; Bergink, V. Guidelines on treatment of perinatal depression with antidepressants: An international review. Aust. N. Zeal. J. Psychiatry 2018, 52, 320-327.
Marx, W.; Moseley, G.; Berk, M.; Jacka, F. Nutritional psychiatry: The present state of the evidence.Proc. Nutr. Soc. 2017, 76, 427-436.
Lauritzen, L.; Hansen, H.S.; Jørgensen, M.H.; Michaelsen, K.F. The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog. Lipid Res. 2001, 40, 1-94.
Hibbeln, J.R. Seafood consumption, the DHA content of mothers’ milk and prevalence rates of postpartum depression: A cross-national, ecological analysis. J. Affect. Disord. 2002, 69, 15-29.
Dos Santos Vaz, J.; Kac, G.; Emmett, P.; Davis, J.M.; Golding, J.; Hibbeln, J.R. Dietary patterns, n-3 fatty acids intake from seafood and high levels of anxiety symptoms during pregnancy: Findings from the Avon Longitudinal Study of Parents and Children. PLoS ONE 2013, 8, e67671.
Golding, J.; Steer, C.; Emmett, P.; Davis, J.M.; Hibbeln, J.R. High Levels of Depressive Symptoms in Pregnancy with Low Omega-3 Fatty Acid Intake from Fish. Epidemiology 2009, 20, 598-603.
Da Rocha, C.M.M.; Kac, G. High dietary ratio of omega-6 to omega-3 polyunsaturated acids during pregnancy and prevalence of post-partum depression. Matern. Child Nutr. 2012, 8, 36-48.
Chong, M.F.F.; Ong, Y.-L.; Calder, P.C.; Colega, M.; Wong, J.X.Y.; Tan, C.S.; Lim, A.L.; Fisk, H.L.; Cai, S.; Pang, W.W. et al. Long-Chain Polyunsaturated Fatty Acid Status During Pregnancy and Maternal Mental Health in Pregnancy and the Postpartum Period. J. Clin. Psychiatry 2015, 76, e848-e856.
Strøm, M.; Mortensen, E.L.; Halldorsson, T.I.; Thorsdottir, I.; Olsen, S.F. Fish and long-chain n-3 polyunsaturated fatty acid intakes during pregnancy and risk of postpartum depression: A prospective study based on a large national birth cohort. Am. J. Clin. Nutr. 2009, 90, 149-155.
Sioen, I.; van Lieshout, L.; Eilander, A.; Fleith, M.; Lohner, S.; Szommer, A.; Petisca, C.; Eussen, S.; Forsyth, S.; Calder, P.C. et al. Systematic Review on N-3 and N-6 Polyunsaturated Fatty Acid Intake in European Countries in Light of the Current Recommendations—Focus on Specific Population Groups. Ann. Nutr. Metab. 2017, 70, 39-50.
Otto, S.J.; Houwelingen, A.C.; Antal, M.; Manninen, A.; Godfrey, K.; López-Jaramillo, P.; Hornstra, G. Maternal and neonatal essential fatty acid status in phospholipids: An international comparative study. Eur. J. Clin. Nutr. 1997, 51, 232-242.
Al, M.D.; van Houwelingen, A.C.; Kester, A.D.; Hasaart, T.H.; de Jong, A.E.; Hornstra, G. Maternal essential fatty acid patterns during normal pregnancy and their relationship to the neonatal essential fatty acid status. Br. J. Nutr. 1995, 74, 55-68.
Otto, S.J.; de Groot, R.H.M.; Hornstra, G. Increased risk of postpartum depressive symptoms is associated with slower normalization after pregnancy of the functional docosahexaenoic acid status.Prostaglandins Leukot. Essent. Fatty Acids 2003, 69, 237-243.
De Vriese, S.R.; Christophe, A.B.; Maes, M. Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression: Further evidence that lowered n-PUFAs are related to major depression. Life Sci. 2003, 73, 3181-3187.
Markhus, M.W.; Skotheim, S.; Graff, I.E.; Frøyland, L.; Braarud, H.C.; Stormark, K.M.; Malde, M.K. Low omega-3 index in pregnancy is a possible biological risk factor for postpartum depression. PLoS ONE 2013, 8, e67617.
Chalon, S. Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins Leukot. Essent. Fat. Acids 2006, 75, 259-269.
Gerbi, A.; Zérouga, M.; Debray, M.; Durand, G.; Chanez, C.; Bourre, J.M. Effect of fish oil diet on fatty acid composition of phospholipids of brain membranes and on kinetic properties of Na+,K(+)-ATPase isoenzymes of weaned and adult rats. J. Neurochem. 1994, 62, 1560-1569.
Lichtstein, D.; Ilani, A.; Rosen, H.; Horesh, N.; Singh, S.; Buzaglo, N.; Hodes, A. Na+, K+-ATPase Signaling and Bipolar Disorder. Int. J. Mol. Sci. 2018, 19, 2314.
Leonard, B.E. Inflammation and depression: A causal or coincidental link to the pathophysiology? Acta Neuropsychiatr. 2018, 30, 1-16.
Dantzer, R.; O’Connor, J.C.; Freund, G.G.; Johnson, R.W.; Kelley, K.W. From inflammation to sickness and depression: When the immune system subjugates the brain. Nat. Rev. Neurosci. 2008,9, 46-56.
Lin, P.-Y.; Chang, C.-H.; Chong, M.F.-F.; Chen, H.; Su, K.-P. Polyunsaturated Fatty Acids in Perinatal Depression: A Systematic Review and Meta-analysis. Biol. Psychiatry 2017, 82, 560-569.
Trujillo, J.; Vieira, M.C.; Lepsch, J.; Rebelo, F.; Poston, L.; Pasupathy, D.; Kac, G. A systematic review of the associations between maternal nutritional biomarkers and depression and/or anxiety during pregnancy and postpartum. J. Affect. Disord. 2018, 232, 185-203.
Sallis, H.; Steer, C.; Paternoster, L.; Davey Smith, G.; Evans, J. Perinatal depression and omega-3 fatty acids: A Mendelian randomisation study. J. Affect. Disord. 2014, 166, 124-131.
Bodnar, L.M.; Wisner, K.L.; Luther, J.F.; Powers, R.W.; Evans, R.W.; Gallaher, M.J.; Newby, P.K. An exploratory factor analysis of nutritional biomarkers associated with major depression in pregnancy. Public Health Nutr. 2012, 15, 1078-1086.
Mattes, E.; McCarthy, S.; Gong, G.; van Eekelen, J.A.M.; Dunstan, J.; Foster, J.; Prescott, S.L. Maternal mood scores in mid-pregnancy are related to aspects of neonatal immune function. Brain. Behav. Immun. 2009, 23, 380-388.
Parker, G.; Hegarty, B.; Granville-Smith, I.; Ho, J.; Paterson, A.; Gokiert, A.; Hadzi-Pavlovic, D. Is essential fatty acid status in late pregnancy predictive of post-natal depression? Acta Psychiatr. Scand. 2015, 131, 148-156.
Schuchardt, J.P.; Hahn, A. Bioavailability of long-chain omega-3 fatty acids. Prostaglandins Leukot. Essent. Fatty Acids 2013, 89, 1-8.
Hoge, A.; Bernardy, F.; Donneau, A.-F.; Dardenne, N.; Degée, S.; Timmermans, M.; Nisolle, M.; Guillaume, M.; Castronovo, V. Low omega-3 index values and monounsaturated fatty acid levels in early pregnancy: An analysis of maternal erythrocytes fatty acids. Lipids Health Dis. 2018, 17, 63.
Harris, W.S.; Von Schacky, C. The Omega-3 Index: A new risk factor for death from coronary heart disease? Prev. Med. 2004, 39, 212-220.
Stein, G.; Van den Akker, O. The retrospective diagnosis of postnatal depression by questionnaire. J. Psychosom. Res. 1992, 36, 67-75.
World Health Organization WHO. Process of Translation and Adaptation of Instruments; WHO: Geneva, Switzerland, 2010.
Amaru, D.; Le Bon, O. La dépression du post-partum: Corrélats et facteurs prédictifs. Rev. Med. Brux.2014, 35, 10-16.
Calder, P.C. n-3 Fatty acids, inflammation and immunity: New mechanisms to explain old actions. Proc. Nutr. Soc. 2013, 72, 326-336.
Georgin-Lavialle, S.; Moura, D.S.; Salvador, A.; Chauvet-Gelinier, J.-C.; Launay, J.-M.; Damaj, G.; Côté, F.; Soucié, E.; Chandesris, M.-O.; Barète, S. et al. Mast cells’ involvement in inflammation pathways linked to depression: Evidence in mastocytosis. Mol. Psychiatry 2016, 21, 1511-1516.
Maes, M.; Smith, R.; Christophe, A.; Cosyns, P.; Desnyder, R.; Meltzer, H. Fatty acid composition in major depression: Decreased omega 3 fractions in cholesteryl esters and increased C20: 4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids. J. Affect. Disord. 1996, 38, 35-46.
Adams, P.B.; Lawson, S.; Sanigorski, A.; Sinclair, A.J. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids 1996, 31, S157-S161.
Friesen, R.W.; Innis, S.M. Dietary Arachidonic Acid to EPA and DHA Balance Is Increased among Canadian Pregnant Women with Low Fish Intake. J. Nutr. 2009, 139, 2344-2350.
McCullough, L.E.; Miller, E.E.; Calderwood, L.E.; Shivappa, N.; Steck, S.E.; Forman, M.R.; Mendez, M.A.; Fuemmeler, B.F.; Kollins, S.H. et al. Maternal inflammatory diet and adverse pregnancy outcomes: Circulating cytokines and genomic imprinting as potential regulators? Epigenetics 2017, 12, 688-697.
Simopoulos, A.P. Evolutionary Aspects of Diet: The Omega-6/Omega-3 Ratio and the Brain. Mol. Neurobiol. 2011, 44, 203-215.
Van der Wurff, I.S.M.; von Schacky, C.; Bergeland, T.; Leontjevas, R.; Zeegers, M.P.; Kirschner, P.A.; de Groot, R.H.M. Exploring the association between whole blood Omega-3 Index, DHA, EPA, DHA, AA and n-6 DPA, and depression and self-esteem in adolescents of lower general secondary education. Eur. J. Nutr. 2018.
Milte, C.M.; Sinn, N.; Howe, P.R. Polyunsaturated fatty acid status in attention deficit hyperactivity disorder, depression, and Alzheimer’s disease: Towards an omega-3 index for mental health? Nutr. Rev. 2009, 67, 573-590.
Bigornia, S.J.; Harris, W.S.; Falcón, L.M.; Ordovás, J.M.; Lai, C.-Q.; Tucker, K.L. The Omega-3 Index Is Inversely Associated with Depressive Symptoms among Individuals with Elevated Oxidative Stress Biomarkers. J. Nutr. 2015, 146, 758-766.
Baghai, T.C.; Varallo-Bedarida, G.; Born, C.; Häfner, S.; Schüle, C.; Eser, D.; Rupprecht, R.; Bondy, B.; von Schacky, C. Major Depressive Disorder Is Associated With Cardiovascular Risk Factors and Low Omega-3 Index. J. Clin. Psychiatry 2011, 72, 1242-1247.
Sparling, T.M.; Nesbitt, R.C.; Henschke, N.; Gabrysch, S. Nutrients and perinatal depression: A systematic review. J. Nutr. Sci. 2017, 6, e61.
Hsu, M.-C.; Tung, C.-Y.; Chen, H.-E. Omega-3 polyunsaturated fatty acid supplementation in prevention and treatment of maternal depression: Putative mechanism and recommendation. J. Affect. Disord. 2018, 238, 47-61.
Vaz, J.; Dos, S.; Farias, D.R.; Adegboye, A.R.A.; Nardi, A.E.; Kac, G. Omega-3 supplementation from pregnancy to postpartum to prevent depressive symptoms: A randomized placebo-controlled trial.BMC Pregnancy Childbirth 2017, 17, 180.
Xie, L.; Innis, S.M. Genetic Variants of the FADS1 FADS2 Gene Cluster Are Associated with Altered (n-6) and (n-3) Essential Fatty Acids in Plasma and Erythrocyte Phospholipids in Women during Pregnancy and in Breast Milk during Lactation. J. Nutr. 2008, 138, 2222-2228.
Meldrum, S.J.; Li, Y.; Zhang, G.; Heaton, A.E.M.; D’Vaz, N.; Manz, J.; Reischl, E.; Koletzko, B.V.; Prescott, S.L.; Simmer, K. Can polymorphisms in the fatty acid desaturase (FADS) gene cluster alter the effects of fish oil supplementation on plasma and erythrocyte fatty acid profiles? An exploratory study. Eur. J. Nutr. 2018, 57, 2583-2594.
Bergmann, R.L.; Haschke-Becher, E.; Klassen-Wigger, P.; Bergmann, K.E.; Richter, R.; Dudenhausen, J.W.; Grathwohl, D.; Haschke, F. Supplementation with 200 mg/day docosahexaenoic acid from mid-pregnancy through lactation improves the docosahexaenoic acid status of mothers with a habitually low fish intake and of their infants. Ann. Nutr. Metab. 2008, 52, 157-166.
Imhoff-Kunsch, B. WHO|Marine Oil Supplementation in Pregnancy and Maternal and Neonatal Health Outcomes. Available online: http://www.who.int/elena/titles/commentary/fish_oil_pregnancy/en/(accessed on 30 January 2018).
Freeman, M.P.; Sinha, P. Tolerability of omega-3 fatty acid supplements in perinatal women.Prostaglandins Leukot. Essent. Fat. Acids 2007, 77, 203-208.
Hoge, A.; Bernardy, F.; Donneau, A.-F.; Dardenne, N.; Degée, S.; Nisolle, M.; Guillaume, M.; Castronovo, V. Importance of n-3 PUFA consumption during pregnancy: Perception discrepancies between pregnant women and gynaecologists-obstetricians in Belgium. Public Health Nutr. 2019.
De Figueiredo, F.P.; Parada, A.P.; Cardoso, V.C.; Batista, R.F.L.; da Silva, A.A.M.; Barbieri, M.A.; de Carvalho Cavalli, R.; Bettiol, H.; Del-Ben, C.M. Postpartum depression screening by telephone: A good alternative for public health and research. Arch. Women’s Ment. Health 2015, 18, 547-553.
Calder, P.C. Functional Roles of Fatty Acids and Their Effects on Human Health. J. Parenter. Enter. Nutr. 2015, 39, 18S-32S.
Innis, S.M. Metabolic programming of long-term outcomes due to fatty acid nutrition in early life. Matern. Child Nutr. 2011, 7 (Suppl. 2), 112-123.
